Diagnostic evaluation of 2′, 5′-oligoadenylate synthetase activities and antibodies against Epstein-Barr virus and Coxiella burnetii in patients with chronic fatigue syndrome in Japan

Microbes and Infection

Volumn 5, Issue 12, 2003, Pages 1096-1102

  Ikuta, Kazufumi ^a   Yamada, Takeshi ^a   Shimomura, Tokio ^b   Kuratsune, Hirohiko ^c   Kawahara, Ryuzo ^a   Ikawa, Shiro ^b   Ohnishi, Eiko ^a   Sokawa, Yoshihiro ^d   Fukushi, Hideto ^e   Hirai, Katsuya ^e   Watanabe, Yasuyoshi ^f   Kurata, Takeshi ^g   Kitani, Teruo ^h   Sairenji, Takeshi ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

^e GIFU UNIVERSITY   (Japan)

^f OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^h Sakai City Hospital   (Japan)

Author keywords

2 , 5 Oligoadenylate synthetase; Chronic fatigue syndrome; Coxiella burnetii; Epstein Barr virus

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; BIOCHEMICAL MARKER; COXIELLA BURNETTI ANTIBODY; EPSTEIN BARR VIRUS ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; COXIELLA BURNETII; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME MECHANISM; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; JAPAN; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; Q FEVER; STATISTICAL ANALYSIS; UPREGULATION; VIRUS INFECTION;

COXIELLA BURNETII; HUMAN HERPESVIRUS 4;

EID: 10744224864     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2003.07.002     Document Type: Article

References (38)

1. Holmes G.P., Kaplan J.E., Gantz N.M., Komaroff A.L., Schonberger L.B., Straus S.E., Jones J.F., Dubois R.E., Cunningham-Rundles C., Pahwa S., Tosato G., Zegans L.S., Purtilo D.T., Brown N., Schooley R.T., Brus I. Chronic fatigue syndrome: a working case definition. Ann. Intern. M. 108:1988;387-389.
2. Vojdani A., Choppa P.C., Lapp C.W. Downregulation of RNase L inhibitor correlates with upregulation of interferon-induced proteins (2-5A synthetase and RNase L) in patients with chronic fatigue immune dysfunction syndrome. J. Clin. Lab. Immunol. 50:1998;1-16.
3. Roberts W.K., Hovanessian A., Brown R.E., Clements M.J., Kerr I.M. Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis. Nature. 264:1976;477-480.
4. Kerr I.M., Brown R.E., Hovanessian A. Nature of inhibitor of cell-free protein synthesis formed in response to interferon and double-stranded RNA. Nature. 268:1977;540-542.
5. Kerr I.M., Brown R.E. pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc. Natl. Acad. Sci. USA. 75:1978;256-260.
6. Schattner A., Merlin G., Wallach D., Levin S., Hahn T., Revel M. Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral disease. Lancet. II:1981;497.
7. Farrar M.A., Schreiber R.D. The molecular cell biology of interferon-gamma and its receptor. Ann. Rev. Immunol. 11:1993;571-611.
8. Licinio J., Kling M.A., Hauser P. Cytokines and brain function: relevance to interferon-α-induced mood and cognitive changes. Semin. Oncol. 25:1998;30-38.
9. Valentine A.D., Meyers C.A., Kling M.A., Richelson E., Hauser P. Mood and cognitive side effects of interferon-α therapy. Semin. Oncol. 25:1998;39-47.
10. Sairenji T., Yamanishi K., Tachibana Y., Bertoni G., Kurata T. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome. Intervirology. 38:1995;269-273.
11. Buchwald D., Sullivan J.L., Komaroff A.L. Frequency of 'chronic active Epstein-Barr virus infection' in a general medical practice. J. Am. Med. Assoc. 257:1987;2303-2307.
12. Bca O.G., Paretsky D. Q fever and Coxiella burnetii: a model for host-parasite interactions. Microbiol. Rev. 47:1983;127-149.
13. Wildman M.J., Smith E.G., Groves J., Beattie J.M., Caul E.O., Ayres J.G. Chronic fatigue following infection by Coxiella burnetii (Q fever): ten-year follow-up of the 1989 UK outbreak cohort. Q. J. M. 95:2002;527-538.
14. Penttila I.A., Harris R.J., Storm P., Haynes D., Worswick D.A., Marmion B.P. Cytokine dysregulation in the post-Q-fever fatigue syndrome. Q. J. M. 91:1998;549-560.
15. Boyum A. Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Lab. Invest. 21:1968;1-109.
16. Sokawa Y., Ando T., Ishihara Y. Induction of 2′, 5′-oligoadenylate synthetase and interferon in mouse trigeminal ganglia infected with herpes simplex virus. Infect. Immun. 28:1980;719-723.
17. Ohnishi E., Iwata T., Inoue S., Kurata T., Sairenji T. Interleukin-4 production in Epstein-Barr virus-transformed B cell lines from peripheral mononuclear cells of patients with atopic dermatitis. J. Interferon Cytokine Res. 17:1997;597-602.
18. Henle W., Henle G., Horwiz C.A. The Epstein-Barr virus specific diagnostic tests in infectious mononucleosis. Human Pathol. 5:1974;551-565.
19. Nguyen S.V., Otsuka H., Zhang G.Q., To H., Yamaguchi H., Fukushi H., Noma A., Hirai K. Rapid method for detection of Coxiella burnetii antibodies using high-density particle agglutination. J. Clin. Microbiol. 34:1996;2947-2951.
20. Ida S., Sairenji T., Hinuma Y. Antibodies to a new antigen induced by Epstein-Barr virus in patients with nasopharyngeal carcinoma, leukemia, malignant lymphoma, and in control groups. Gann. 63:1972;49-55.
21. Laroche C., Drouet E.B., Brousset P., Pain C., Boibieux A., Biron F., Icart J., Denoyel G.A., Niveleau A. Measurement by the polymerase chain reaction of the Epstein-Barr virus load in infectious mononucleosis and AIDS-related non-Hodgkin's lymphomas. J. Med. Virol. 46:1995;66-74.
22. Yoshioka M., Ishiguro N., Ishiko H., Ma X., Kikuta H., Kobayashi K. Heterogeneous, restricted patterns of Epstein-Barr virus (EBV) latent gene expression in patients with chronic active EBV infection. J. Gen. Virol. 82:2001;2385-2392.
23. Ikuta K., Satoh Y., Hoshikawa Y., Sairenji T. Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children. Microbes Infect. 2:2000;115-120.
24. Ikuta K., Saiga K., Deguchi M., Sairenji T. Epstein-Barr virus DNA is detected in peripheral blood mononuclear cells of EBV-seronegative infants with infectious mononucleosis-like symptoms. Virus Genes. 26:2003;165-173.
25. Marrie T.J. "Q fever", The Diseases. 1990;CRC Press, Boston.
26. Williams J.C., Thompson H.A. "Q fever: The Coxiella burnetii" 1991;CRC Press, Boston.
27. Ejercito C.L., Cai L., Htwe K.K., Taki M., Inoshima Y., Kondo T., Kano C., Abe S., Shirota K., Sugimoto T. Serological evidence of Coxiella burnetii infection in wild animals in Japan. J. Wildlife Dis. 29:1993;481-484.
28. Htwe K.K., Amano K., Sugiyama Y., Yagami K., Minamoto N., Hashimoto A., Yamaguchi T., Fukushi H., Hirai K. Seroepidemiology of Coxiella burnetii in domestic and companion animals in Japan. Vet. Rec. 131:1992;490.
29. Htwe K.K., Yoshida T., Hayashi S., Miyake T., Amano K., Morita C., Yamaguchi T., Fukushi H., Hirai K. Prevalence of antibodies to Coxiella burnetii in Japan. J. Clin. Microbiol. 31:1993;722-723.
30. Nagaoka H., Akiyama M., Sugieda M., Nishio T., Akahane S., Hattori H., Ho T., Fukushi H., Hirai K. Isolation of Coxiella burnetii from children with influenza-like symptoms in Japan. Microbiol. Immunol. 40:1996;147-151.
31. Vojdani A., Lapp C.W. Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome. Immunopharmacol. Immunotoxicol. 21:1999;175-202.
32. Natelson B.H., Ye N., Moul D.E., Jenkins F.J., Oren D.A., Tapp W.N., Cheng Y.C. High titers of anti-Epstein-Barr virus DNA polymerase are found in patients with severe fatiguing illness. J. Med. Virol. 42:1994;42-46.
33. Di Luca D., Zorzenon M., Mirandola P., Colle R., Botta G.A., Cassai E. Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome. J. Clin. Microbiol. 33:1995;1660-1661.
34. Buchwald D., Cheney P.R., Peterson D.L., Henry B., Wormsley S.B., Geiger A., Ablashi D.V., Salahuddin S.Z., Saxinger C., Biddle R., Kikinis R., Jolesz F.A., Folks T., Balachandran N., Peter J.B., Gallo R.C., Komaroff A.L. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann. Intern. M. 116:1992;103-113.
35. Kitani T., Kuratsune H., Fuke I., Nakamura Y., Nakaya T., Asashi S., Tobiume M., Yamaguchi K., Machii T., Inaga R., Yamanishi K., Ikuta K. Possible correlation between Borna diseases virus infection and Japanese patients with chronic fatigue syndrome. Microbiol. Immunol. 40:1996;459-462.
36. Nakaya T., Takahashi H., Nakamura Y., Asahi S., Tobiume M., Kuratsune H., Kitani T., Yamanishi K., Ikuta K. Demonstration of Borna disease virus RNA in peripheral blood mononuclear cells derived from Japanese patients with chronic fatigue syndrome. FEBS Lett. 378:1996;145-149.
37. Suhadolnik R.J., Peterson D.L., O'brien K., Cheney P.R., Herst C.V.T., Reichenbach N.L., Kon N., Horvath S.E., Iacono K.T., Adelson M.E., Meirleir K.D., Becker P.D., Charubala R., Pfleiderer W. Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome. J. Interferon Cytokine Res. 17:1997;377-385.
38. Demettre E., Bastide L., D'Haese A., Smet K.D., Meirleir K.D., Tiev K.P., Englebienne P., Lebleu B. Ribonuclease L proteolysis in peripheral blood mononuclear cells of chronic fatigue syndrome patients. J. Biol. Chem. 277:2002;35746-35751.